130 related articles for article (PubMed ID: 32231397)
1. Efficacy of a small molecule inhibitor of the transcriptional cofactor PC4 in prevention and treatment of non-small cell lung cancer.
Zhang Y; Pavlov A; Malik S; Chen H; Kim N; Li Z; Zhang X; DePamphilis ML; Roeder RG; Ge H
PLoS One; 2020; 15(3):e0230670. PubMed ID: 32231397
[TBL] [Abstract][Full Text] [Related]
2. Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer.
Peng Y; Yang J; Zhang E; Sun H; Wang Q; Wang T; Su Y; Shi C
Cancer Gene Ther; 2012 Oct; 19(10):690-6. PubMed ID: 22918472
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PC4 radiosensitizes non-small cell lung cancer by transcriptionally suppressing XLF.
Zhang T; Liu X; Chen X; Wang J; Wang Y; Qian D; Pang Q; Wang P
Cancer Med; 2018 Apr; 7(4):1326-1337. PubMed ID: 29522271
[TBL] [Abstract][Full Text] [Related]
4. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the interacting domains of the positive coactivator PC4 with the transcription factor AP-2alpha.
Zhong L; Wang Y; Kannan P; Tainsky MA
Gene; 2003 Nov; 320():155-64. PubMed ID: 14597399
[TBL] [Abstract][Full Text] [Related]
6. An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signalling.
Lin PL; Wu TC; Wu DW; Wang L; Chen CY; Lee H
Eur J Cancer; 2017 Nov; 85():95-105. PubMed ID: 28892778
[TBL] [Abstract][Full Text] [Related]
7. Coactivator function of positive cofactor 4 (PC4) in Sp1-directed luteinizing hormone receptor (LHR) gene transcription.
Liao M; Zhang Y; Kang JH; Dufau ML
J Biol Chem; 2011 Mar; 286(9):7681-91. PubMed ID: 21193408
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
Zhu X; Gao G; Chu K; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
Int J Biochem Cell Biol; 2015 Apr; 61():103-14. PubMed ID: 25687035
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of PC4 increases chemosensitivity of Oxaliplatin in triple negative breast cancer by suppressing mTOR pathway.
Wang Q; Ma L; Chen L; Chen H; Luo M; Yang W; Liao F; Gong Q; Wang Y; Yang Z; Wu J; Zhang C; Zheng J; Han S; Leng Y; Luo P; Shi C
Biochem Biophys Res Commun; 2021 Mar; 544():65-72. PubMed ID: 33524870
[TBL] [Abstract][Full Text] [Related]
10. Human positive coactivator 4 (PC4) is involved in the progression and prognosis of astrocytoma.
Chen L; Du C; Wang L; Yang C; Zhang JR; Li N; Li Y; Xie XD; Gao GD
J Neurol Sci; 2014 Nov; 346(1-2):293-8. PubMed ID: 25262015
[TBL] [Abstract][Full Text] [Related]
11. Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
Tang Q; Zheng F; Wu J; Xiao Q; Li L; Hann SS
Cell Physiol Biochem; 2017; 43(6):2310-2326. PubMed ID: 29073599
[TBL] [Abstract][Full Text] [Related]
12. Purification, cloning, and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes.
Ge H; Roeder RG
Cell; 1994 Aug; 78(3):513-23. PubMed ID: 8062391
[TBL] [Abstract][Full Text] [Related]
13. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Li X; Wang X; Ye H; Peng A; Chen L
Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
[TBL] [Abstract][Full Text] [Related]
14. ETS-1 Induces Endothelial-Like Differentiation and Promotes Metastasis in Non-Small Cell Lung Cancer.
Zhou X; Zhou R; Zhou H; Li Q; Hong J; Meng R; Zhu F; Zhang S; Dai X; Peng G; Wu G; Li Z
Cell Physiol Biochem; 2018; 45(5):1827-1839. PubMed ID: 29510376
[TBL] [Abstract][Full Text] [Related]
15. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
16. MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity
Son DJ; Zheng J; Jung YY; Hwang CJ; Lee HP; Woo JR; Baek SY; Ham YW; Kang MW; Shong M; Kweon GR; Song MJ; Jung JK; Han SB; Kim BY; Yoon DY; Choi BY; Hong JT
Theranostics; 2017; 7(18):4632-4642. PubMed ID: 29158850
[No Abstract] [Full Text] [Related]
17. PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells.
Zhao XM; Pan SY; Huang QL; Lu YN; Wu XH; Chang JH; Liu ZB; Cai XW; Liu Q; Wang JL; Fu XL
Oncotarget; 2016 Aug; 7(31):49384-49396. PubMed ID: 27283902
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-Myc mediated Warburg effect.
Luo P; Zhang C; Liao F; Chen L; Liu Z; Long L; Jiang Z; Wang Y; Wang Z; Liu Z; Miao H; Shi C
Cell Commun Signal; 2019 Apr; 17(1):36. PubMed ID: 30992017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]